1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus H Masur, JE Kaplan, KK Holmes, BL Alston, N Ampel, JR Anderson, ... Clinical Infectious Diseases 30, S29-S65, 2000 | 910* | 2000 |
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study I Hickie, T Davenport, D Wakefield, U Vollmer-Conna, B Cameron, ... Bmj 333 (7568), 575, 2006 | 859 | 2006 |
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution WC Reeves, A Lloyd, SD Vernon, N Klimas, LA Jason, G Bleijenberg, ... BMC health services research 3, 1-9, 2003 | 526 | 2003 |
Comprehensive serological profiling of human populations using a synthetic human virome GJ Xu, T Kula, Q Xu, MZ Li, SD Vernon, T Ndung’u, K Ruxrungtham, ... Science 348 (6239), aaa0698, 2015 | 450 | 2015 |
Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies MS Rajeevan, DG Ranamukhaarachchi, SD Vernon, ER Unger Methods 25 (4), 443-451, 2001 | 435 | 2001 |
Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR MS Rajeevan, SD Vernon, N Taysavang, ER Unger The Journal of Molecular Diagnostics 3 (1), 26-31, 2001 | 421 | 2001 |
Chronic fatigue syndrome–a clinically empirical approach to its definition and study WC Reeves, D Wagner, R Nisenbaum, JF Jones, B Gurbaxani, ... BMC medicine 3, 1-9, 2005 | 372 | 2005 |
The economic impact of chronic fatigue syndrome KJ Reynolds, SD Vernon, E Bouchery, WC Reeves Cost effectiveness and resource allocation 2, 1-9, 2004 | 332 | 2004 |
A formal analysis of cytokine networks in chronic fatigue syndrome G Broderick, J Fuite, A Kreitz, SD Vernon, N Klimas, MA Fletcher Brain, behavior, and immunity 24 (7), 1209-1217, 2010 | 275 | 2010 |
Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 259 | 2023 |
The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription SD Vernon, CE Hart, WC Reeves, JP Icenogle Virus research 27 (2), 133-145, 1993 | 207 | 1993 |
Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome AP Presson, EM Sobel, JC Papp, CJ Suarez, T Whistler, MS Rajeevan, ... BMC systems biology 2, 1-21, 2008 | 199 | 2008 |
Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture SD Vernon, ER Unger, D Williams Journal of clinical microbiology 38 (2), 651-655, 2000 | 196 | 2000 |
Association of human papillomavirus type 16 integration in the E2 gene with poor disease‐free survival from cervical cancer SD Vernon, ER Unger, DL Miller, DR Lee, WC Reeves International journal of cancer 74 (1), 50-56, 1997 | 171 | 1997 |
Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability S Gupta, E Aslakson, BM Gurbaxani, SD Vernon Theoretical Biology and Medical Modelling 4, 1-12, 2007 | 146 | 2007 |
Changes in gut and plasma microbiome following exercise challenge in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) SK Shukla, D Cook, J Meyer, SD Vernon, T Le, D Clevidence, ... PloS one 10 (12), e0145453, 2015 | 131 | 2015 |
Integration of gene expression data and non-gene data S Vernon, A Yavatkar, E Unger, W Reeves, D Bui, S Lucas US Patent App. 11/140,596, 2006 | 124 | 2006 |
Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome MS Rajeevan, AK Smith, I Dimulescu, ER Unger, SD Vernon, C Heim, ... Genes, Brain and Behavior 6 (2), 167-176, 2007 | 113 | 2007 |
Impaired immune function in Gulf War illness T Whistler, MA Fletcher, W Lonergan, XR Zeng, JM Lin, A LaPerriere, ... BMC medical genomics 2, 1-13, 2009 | 102 | 2009 |
Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome SD Vernon, ER Unger, IM Dimulescu, M Rajeevan, WC Reeves Disease markers 18 (4), 193-199, 2002 | 99 | 2002 |